4:00PM Array Biopharma and Global Blood Therapeutics announce drug discovery collaboration focused on hematology (ARRY) 4.37 +0.07 : Co announced a multi-target drug discovery collaboration agreement to identify small molecule lead compounds targeting chronic blood-based diseases. Array will develop assays and screen its proprietary lead generation library of 300,000 small molecules to identify both active site and allosteric modulators of certain Global Blood targets. Array's library will allow for rapid hit confirmation and subsequent lead optimization.
Recent ARRY News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 09:14:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 09:10:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 09:05:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 06:38:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 11:56:11 PM
- APA Solar Racking Announces Opening of New Headquarters in Ohio • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/25/2026 09:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 01:02:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 09:27:42 PM
- ARRAY Technologies Bolsters Board With Two Additional Directors • GlobeNewswire Inc. • 03/19/2026 09:23:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:03:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:07:12 PM
- ARRAY Technologies Reports Financial Results for the Fourth Quarter and Full Year 2025 • GlobeNewswire Inc. • 02/25/2026 09:05:00 PM
- ARRAY Technologies to Participate in Upcoming Conference for the Investor Community • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:21:04 PM
- ARRAY Technologies Upsizes and Extends Revolving Credit Facility to $370 Million, Strengthening Liquidity and Strategic Flexibility • GlobeNewswire Inc. • 02/18/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:05:38 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:17:33 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/06/2026 05:08:56 PM
- ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call • GlobeNewswire Inc. • 02/04/2026 09:05:00 PM
- ARRAY Technologies Promotes Darin Green to Global Chief Revenue Officer and Nick Strevel to Chief Product Officer • GlobeNewswire Inc. • 01/06/2026 02:00:00 PM
- ARRAY Technologies, Inc. to Participate in Upcoming Events for the Investor Community • GlobeNewswire Inc. • 11/14/2025 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 10:16:58 PM

